EQUITY EXCHANGE RIGHT AGREEMENTEquity Exchange Right Agreement • May 12th, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 12th, 2021 Company Industry JurisdictionTHIS EQUITY EXCHANGE RIGHT AGREEMENT (this “Agreement”) is made and entered into as of April 20, 2021, by and between Recursion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Christopher Gibson (the “Founder”).
EXCHANGE AGREEMENTExchange Agreement • May 12th, 2021 • Recursion Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 12th, 2021 Company Industry JurisdictionTHIS EXCHANGE AGREEMENT (this “Agreement”) is made and entered into as of April 20, 2021, by and between Recursion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and stockholders of the Company listed on Exhibit A hereto (collectively, the “Exchange Stockholders”).